| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 26.83▼ | 26.90▼ | 26.90▼ | 27.12▼ | 26.27▲ |
| MA10 | 26.95▼ | 26.96▼ | 26.90▼ | 26.65▼ | 25.74▲ |
| MA20 | 26.48▲ | 26.42▲ | 26.37▲ | 26.37▲ | 25.57▲ |
| MA50 | 25.08▲ | 25.37▲ | 25.48▲ | 25.66▲ | 25.28▲ |
| MA100 | 25.37▲ | 25.21▲ | 25.10▲ | 25.43▲ | N/A |
| MA200 | 24.43▲ | 24.46▲ | 24.49▲ | 24.95▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.067▼ | -0.033▼ | -0.009▼ | 0.061▲ | 0.151▲ |
| RSI | 56.971▲ | 56.450▲ | 56.910▲ | 53.251▲ | 55.229▲ |
| STOCH | 36.971 | 53.638 | 62.671 | 76.992 | 75.983 |
| WILL %R | -51.682 | -51.682 | -51.682 | -59.038 | -27.169 |
| CCI | -36.114 | -18.022 | -5.609 | 17.610 | 137.755▲ |
| MA | $OZEM Price Crossed Below MA(7) | Set Alert |
|
Thursday, September 18, 2025 03:44 AM
Novo Nordisk (NVO) shares rose 6% premarket on Thursday after a real-world study showed its diabetes drug Ozempic outperformed Eli Lilly’s (NYSE:LLY) older drug Trulicity (dulaglutide) in certain ...
|
|
Friday, September 05, 2025 08:24 AM
NuCana (NCNA) announced that it has received formal notification from The Nasdaq Stock Market on September 4, 2025 confirming that the Company is in compliance with all applicable Nasdaq continued ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/09/25 | 26.96 | 26.96 | 26.42 | 26.512 | 26,200 |
| 24/09/25 | 27.24 | 27.408 | 27.13 | 27.378 | 5,700 |
| 23/09/25 | 27.51 | 27.51 | 27.20 | 27.2211 | 5,062 |
| 22/09/25 | 27.30 | 27.74 | 27.27 | 27.605 | 16,100 |
| 19/09/25 | 27.18 | 27.31 | 26.85 | 26.8825 | 10,265 |
| 18/09/25 | 26.72 | 27.115 | 26.72 | 27.115 | 20,600 |
| 17/09/25 | 26.28 | 26.46 | 26.167 | 26.167 | 5,800 |
| 16/09/25 | 25.93 | 26.28 | 25.93 | 26.0607 | 10,312 |
| 15/09/25 | 25.95 | 26.0003 | 25.80 | 25.80 | 4,556 |
| 12/09/25 | 26.03 | 26.03 | 25.66 | 25.79 | 5,800 |
|
|
||||
|
|
||||
|
|